» Articles » PMID: 3603036

Delay Time of Hemoglobin S Polymerization Prevents Most Cells from Sickling in Vivo

Overview
Journal Science
Specialty Science
Date 1987 Jul 31
PMID 3603036
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

A laser photolysis technique has been developed to assess the quantitative significance of the delay time of hemoglobin S gelation to the pathophysiology of sickle cell disease. Changes in the saturation of hemoglobin S with carbon monoxide produced by varying the intensity of a photolytic laser beam were used to simulate changes in the saturation of oxyhemoglobin S produced by variations in oxygen pressure. The presence of polymer at steady-state saturation with carbon monoxide was determined by measurement of the kinetics of gelation after complete photodissociation. The kinetics are a very sensitive probe for polymer since small amounts of polymerized hemoglobin increase the rate of nucleation sufficiently to eliminate the delay period. First, the equilibrium gelation properties of partially photodissociated carbonmonoxyhemoglobin S were shown to be the same as partially oxygenated hemoglobin S, and the method was then used to determine the effect of saturation on the formation and disappearance of polymers in individual sickle cells. The saturation at which polymers first formed upon deoxygenation was much lower than the saturation at which polymers disappeared upon reoxygenation. The results indicate that at venous saturations with oxygen, gelation takes place in most cells at equilibrium, but is prevented from occurring in vivo because the delay times are sufficiently long that most cells return to the lungs and are reoxygenated before polymerization has begun.

Citing Articles

Post-GWAS Validation of Target Genes Associated with HbF and HbA Levels.

Caria C, Faa V, Porcu S, Marongiu M, Poddie D, Perseu L Cells. 2024; 13(14.

PMID: 39056767 PMC: 11274989. DOI: 10.3390/cells13141185.


A framework of computer vision-enhanced microfluidic approach for automated assessment of the transient sickling kinetics in sickle red blood cells.

Qiang Y, Xu M, Patel Pochron M, Jupelli M, Dao M Front Phys. 2024; 12.

PMID: 38605818 PMC: 11008125. DOI: 10.3389/fphy.2024.1331047.


Clinical and laboratory factors associated with splenic dysfunction among patients with sickle cell disease in a malaria endemic region.

Ladu A, Satumari N, Abba A, Abulfathi F, Jeffery C, Adekile A Trans R Soc Trop Med Hyg. 2023; 117(12):859-866.

PMID: 37615662 PMC: 10695422. DOI: 10.1093/trstmh/trad059.


Voxelotor does not inhibit sickle hemoglobin fiber formation upon complete deoxygenation.

Worth E, Fugate M, Ferrone F Biophys J. 2023; 122(13):2782-2790.

PMID: 37270670 PMC: 10397806. DOI: 10.1016/j.bpj.2023.05.034.


Intravenous Fluid Administration and the Risk of Adverse Outcomes in Sickle Cell Disease Patients Hospitalized for Vaso-Occlusive Crisis.

Ojo A, Ojukwu S, Asmare W, Odipe O, Larbi D J Hematol. 2022; 11(5):159-166.

PMID: 36406833 PMC: 9635800. DOI: 10.14740/jh1058.